Skip to Main Content

Advertisement

Skip Nav Destination

In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection.

J Exp Med (1987) 165 (3): 650–656.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal